Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery.
(2015) In Perioperative Medicine 4.- Abstract
- The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure-not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the "Lund concept" of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8159812
- author
- Li, N ; Statkevicius, Svajunas LU ; Asgeirsson, Bogi LU and Schött, Ulf LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Perioperative Medicine
- volume
- 4
- article number
- 9
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:26425342
- pmid:26425342
- wos:000215777000009
- ISSN
- 2047-0525
- DOI
- 10.1186/s13741-015-0019-7
- project
- Koagulation vid kirurgi och kritisk sjukdom
- language
- English
- LU publication?
- yes
- id
- 3f5b96d9-55d4-4557-90ed-dd3e528705a5 (old id 8159812)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26425342?dopt=Abstract
- date added to LUP
- 2016-04-01 13:50:17
- date last changed
- 2018-11-21 20:20:22
@article{3f5b96d9-55d4-4557-90ed-dd3e528705a5, abstract = {{The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure-not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the "Lund concept" of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy.}}, author = {{Li, N and Statkevicius, Svajunas and Asgeirsson, Bogi and Schött, Ulf}}, issn = {{2047-0525}}, language = {{eng}}, publisher = {{BioMed Central (BMC)}}, series = {{Perioperative Medicine}}, title = {{Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery.}}, url = {{https://lup.lub.lu.se/search/files/3617078/8840948}}, doi = {{10.1186/s13741-015-0019-7}}, volume = {{4}}, year = {{2015}}, }